Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil.
Cho YS, Noh YH, Lim HS, Cho SH, Ghim JL, Choe S, Kim SB, Park JS, Lee SK, Yang WS, Chang JW, Bahng MY, Bae KS. Cho YS, et al. Among authors: ghim jl. J Clin Pharmacol. 2018 Jul;58(7):905-912. doi: 10.1002/jcph.1095. Epub 2018 Mar 14. J Clin Pharmacol. 2018. PMID: 29537612
Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
Cho SH, Lim HS, Ghim JL, Choe S, Kim UJ, Jung JA, Bae KS. Cho SH, et al. Among authors: ghim jl. Clin Ther. 2009 May;31(5):1046-53. doi: 10.1016/j.clinthera.2009.05.013. Clin Ther. 2009. PMID: 19539105 Clinical Trial.
Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.
Jung J, Choi S, Cho SH, Ghim JL, Hwang A, Kim U, Kim BS, Koguchi A, Miyoshi S, Okabe H, Bae KS, Lim HS. Jung J, et al. Among authors: ghim jl. Clin Ther. 2010 Jun;32(6):1178-87. doi: 10.1016/j.clinthera.2010.06.011. Clin Ther. 2010. PMID: 20637970 Clinical Trial.
Evaluation of pharmacokinetic and pharmacodynamic profiles and tolerability after single (2.5, 5, or 10 mg) and repeated (2.5, 5, or 10 mg bid for 4.5 days) oral administration of ivabradine in healthy male Korean volunteers.
Choi HY, Noh YH, Cho SH, Ghim JL, Choe S, Kim UJ, Ah Jung J, Bae KS, Lim HS. Choi HY, et al. Among authors: ghim jl. Clin Ther. 2013 Jun;35(6):819-35. doi: 10.1016/j.clinthera.2013.04.012. Epub 2013 Jun 4. Clin Ther. 2013. PMID: 23755867 Clinical Trial.
54 results